Lewis T Williams - Net Worth and Insider Trading
Lewis T Williams Net Worth
The estimated net worth of Lewis T Williams is at least $16 Million dollars as of 2024-06-05. Lewis T Williams is the President, CEO and Chairman of Five Prime Therapeutics Inc and owns about 433,892 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $16 Million. Details can be seen in Lewis T Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lewis T Williams has not made any transactions after 2016-12-23 and currently still holds the listed stock(s).
Transaction Summary of Lewis T Williams
Lewis T Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lewis T Williams owns 4 companies in total, including Protagonist Therapeutics Inc (PTGX) , Neoleukin Therapeutics Inc (NLTX) , and Five Prime Therapeutics Inc (FPRX) among others .
Click here to see the complete history of Lewis T Williams’s form 4 insider trades.
Insider Ownership Summary of Lewis T Williams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2022-05-26 | director |
| NLTX | Neoleukin Therapeutics Inc | 2019-10-10 | director |
| FPRX | Five Prime Therapeutics Inc | 2019-09-01 | director |
 | | 2022-02-03 | director |
Lewis T Williams Latest Holdings Summary
Lewis T Williams currently owns a total of 1 stock. Lewis T Williams owns 433,892 shares of Five Prime Therapeutics Inc (FPRX) as of December 23, 2016, with a value of $16 Million.
Latest Holdings of Lewis T Williams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2016-12-23 | 433,892 | 38.00 | 16,487,896 |
Holding Weightings of Lewis T Williams
Lewis T Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, Lewis T Williams has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the sale of 30,000 shares on December 23, 2016, which brought Lewis T Williams around $2 Million.
Insider Trading History of Lewis T Williams
- 1
Lewis T Williams Trading Performance
Lewis T Williams Ownership Network
Lewis T Williams Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Lewis T Williams is the director of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , director & President and CEO Patel Dinesh V Ph D , and Chief Development Officer Suneel Gupta .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Lewis T Williams made no insider transaction in Protagonist Therapeutics Inc (PTGX). Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 130,000 shares made by Patel Dinesh V Ph D , a net sale of 25,421 shares made by Asif Ali , and a net sale of 12,975 shares made by William D. Waddill .
In summary, during the past 3 months, insiders sold 26,234 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 26,234 shares. During the past 18 months, 175,244 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 175,244 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Lewis T Williams Mailing Address
Above is the net worth, insider trading, and ownership report for Lewis T Williams. You might contact Lewis T Williams via mailing address: C/o Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
